<DOC>
	<DOC>NCT00146640</DOC>
	<brief_summary>The objective of this study is to investigate if low doses of prednisone TRT, given at night and, with active drug release at 2 am, are more effective in controlling joint stiffness, and other disease symptoms of rheumatoid arthritis than standard prednisone given in the morning. Treatment duration per patient takes 12 months (the double-blind comparative study takes 3 months; 9 months subsequent open treatment on the TRT-medication).</brief_summary>
	<brief_title>Prednisone Timed-Release Tablet (TRT) Study: TRT Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Active disease (inflammatory signs, erythrocyte sedimentation rate [ESR], Creactive protein [CRP]) Stable condition Stable basic treatments Morning stiffness on previous treatment with standard prednisone (below or equal to 10mg per day) equal to or above 45 minutes All contraindications for glucocorticoids Pregnancy Concomitant treatment with biologics Intraarticular injections or synovectomy within the previous 4 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>active disease</keyword>
	<keyword>morning stiffness of joints</keyword>
	<keyword>nighttime application of prednisone</keyword>
	<keyword>modified releae prednisone</keyword>
</DOC>